Sacral neuromodulation versus personalized conservative treatment in patients with idiopathic slow-transit constipation

Autor: Carmen D. Dirksen, S. M. J. van Kuijk, Stella C.M. Heemskerk, Jarno Melenhorst, Adriënne H Rotteveel, Marc A. Benninga, Stephanie O. Breukink, C. I. M. Baeten, Ad A.M. Masclee
Přispěvatelé: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, RS: NUTRIM - R2 - Liver and digestive health, RS: CAPHRI - R2 - Creating Value-Based Health Care, MUMC+: KIO Kemta (9), Promovendi NTM, Surgery, Interne Geneeskunde, MUMC+: MA Maag Darm Lever (9), MUMC+: MA Heelkunde (9), Health Services Research, Amsterdam Gastroenterology Endocrinology Metabolism, Paediatric Gastroenterology
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Constipation
Cost effectiveness
Constipation/economics
Cost-Benefit Analysis
CHILDREN
SURGICAL COMPLICATIONS
Conservative Treatment
law.invention
Cohort Studies
0302 clinical medicine
Quality of life
Randomized controlled trial
law
QUALITY-OF-LIFE
Sacrum/innervation
ADOLESCENTS
Medicine
Clinical Study Protocol
Reimbursement
health care economics and organizations
Gastroenterology
Gastrointestinal Transit/physiology
Cost-effectiveness analysis
030220 oncology & carcinogenesis
030211 gastroenterology & hepatology
medicine.symptom
Electric Stimulation Therapy/adverse effects
Sacrum
medicine.medical_specialty
QUESTIONNAIRE
Electric Stimulation Therapy
CONTROLLED CROSSOVER
CLASSIFICATION
03 medical and health sciences
MANAGEMENT
Humans
MODULATION
Gastrointestinal Transit
NERVE-STIMULATION
business.industry
Sacral neuromodulation
medicine.disease
Rectal prolapse
Sample Size
Physical therapy
Defecation
Cost-effectiveness
business
Zdroj: International Journal of Colorectal Disease, 33(4), 493-501. Springer, Cham
International journal of colorectal disease, 33(4), 493-501. Springer Verlag
International Journal of Colorectal Disease
ISSN: 0179-1958
DOI: 10.1007/s00384-018-2978-x
Popis: Purpose The evidence regarding the (cost-)effectiveness of sacral neuromodulation (SNM) in patients with therapy-resistant idiopathic slow-transit constipation is of suboptimal quality. The Dutch Ministry of Health, Welfare and Sports has granted conditional reimbursement for SNM treatment. The objective is to assess the effectiveness, cost-effectiveness, and budget impact of SNM compared to personalized conservative treatment (PCT) in patients with idiopathic slow-transit constipation refractory to conservative treatment. Methods This study is an open-label, multicenter randomized controlled trial. Patients aged 14 to 80 with slow-transit constipation, a defecation frequency (DF)
Databáze: OpenAIRE
Externí odkaz: